PT93946A - Processo para a preparacao de sais de azelastina com solubilidade melhorada e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de sais de azelastina com solubilidade melhorada e de composicoes farmaceuticas que os contem

Info

Publication number
PT93946A
PT93946A PT93946A PT9394690A PT93946A PT 93946 A PT93946 A PT 93946A PT 93946 A PT93946 A PT 93946A PT 9394690 A PT9394690 A PT 9394690A PT 93946 A PT93946 A PT 93946A
Authority
PT
Portugal
Prior art keywords
azelastine
salts
improved solubility
preparing
contain
Prior art date
Application number
PT93946A
Other languages
English (en)
Other versions
PT93946B (pt
Inventor
Helmut Hettche
Reinhard Muckenshnabel
Gerhard Scheffler
Ilona Fleischhauer
Wolgang Morick
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of PT93946A publication Critical patent/PT93946A/pt
Publication of PT93946B publication Critical patent/PT93946B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PT93946A 1989-05-05 1990-05-03 Processo para a preparacao de sais de azelastina com solubilidade melhorada e de composicoes farmaceuticas que os contem PT93946B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3914859 1989-05-05

Publications (2)

Publication Number Publication Date
PT93946A true PT93946A (pt) 1991-01-08
PT93946B PT93946B (pt) 1996-11-29

Family

ID=6380164

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93946A PT93946B (pt) 1989-05-05 1990-05-03 Processo para a preparacao de sais de azelastina com solubilidade melhorada e de composicoes farmaceuticas que os contem

Country Status (17)

Country Link
US (4) US5086050A (pt)
EP (1) EP0396069B1 (pt)
JP (1) JPH02295987A (pt)
AT (1) ATE107643T1 (pt)
AU (1) AU622022B2 (pt)
CA (1) CA2016089C (pt)
DD (1) DD294254A5 (pt)
DE (2) DE4013696A1 (pt)
DK (1) DK0396069T3 (pt)
ES (1) ES2055216T3 (pt)
FI (1) FI902244A0 (pt)
HU (1) HU206110B (pt)
IE (1) IE63662B1 (pt)
NO (1) NO901985L (pt)
NZ (1) NZ233546A (pt)
PT (1) PT93946B (pt)
YU (1) YU86390A (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
US5296472A (en) * 1991-12-05 1994-03-22 Vyrex Corporation Methods for delipidation of skin and cerumen removal
JP4138910B2 (ja) * 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
US6537969B1 (en) * 1997-10-24 2003-03-25 John P. Blass Nutritional supplement for cerebral metabolic insufficiencies
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
FI982733A (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7694694B2 (en) * 2004-05-10 2010-04-13 The Aerospace Corporation Phase-change valve apparatuses
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
SI2486942T1 (sl) 2004-11-24 2019-03-29 Meda Pharmaceuticals Inc. Sestavki, ki obsegajo azelastin, in postopki za njihovo uporabo
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
EP2697662B1 (en) 2011-04-13 2018-06-06 Codexis, Inc. Biocatalytic process for preparing eslicarbazepine and analogs thereof
US11389458B2 (en) 2019-04-12 2022-07-19 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating parkinson's and huntington's disease
US11690849B2 (en) 2019-04-12 2023-07-04 LA PharmaTech Inc. Method of treating dementia
US11744833B2 (en) 2019-04-12 2023-09-05 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of insomnia
US10898493B2 (en) 2019-04-12 2021-01-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
US10966989B2 (en) 2019-04-12 2021-04-06 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
US11938139B2 (en) 2019-04-12 2024-03-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
US11318144B2 (en) 2019-04-12 2022-05-03 LA PharmaTech Inc. Compositions and methods for treating Alzheimer's disease and Parkinson's disease
US10639314B1 (en) 2019-04-30 2020-05-05 LA PharmaTech Inc. Method of treating Alzheimer's disease
US11351179B1 (en) 2021-08-05 2022-06-07 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH572914A5 (pt) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
DE3575135D1 (de) * 1984-09-14 1990-02-08 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.
EP0222191B1 (de) * 1985-11-11 1991-01-30 ASTA Pharma AG 4-Benzyl-1-(2H)-phthalazinon-Derivate
JPH0667844B2 (ja) * 1987-03-06 1994-08-31 エーザイ株式会社 虚血性心疾患の治療・予防剤
EP0289939A1 (de) * 1987-05-08 1988-11-09 ASTA Pharma AG Neue 4-Benzyl-1-(2H)-phthalazinon-Derivate mit einem Aminosäurerest
AU609210B2 (en) * 1987-11-13 1991-04-26 Viatris Gmbh & Co. Kg Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
US5232919A (en) * 1987-11-13 1993-08-03 Asta Pharma Aktiengesellschaft Azelastine embonate and compositions which contain it
EP0316639B1 (de) * 1987-11-13 1994-06-08 ASTA Medica Aktiengesellschaft Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten
JP2794021B2 (ja) * 1988-11-02 1998-09-03 エーザイ株式会社 アゼラスチン或いはその塩類含有経皮適用製剤

Also Published As

Publication number Publication date
US5086050A (en) 1992-02-04
NO901985D0 (no) 1990-05-04
AU5473690A (en) 1990-11-08
DE4013696A1 (de) 1990-11-08
CA2016089A1 (en) 1990-11-05
NZ233546A (en) 1991-09-25
PT93946B (pt) 1996-11-29
DD294254A5 (de) 1991-09-26
AU622022B2 (en) 1992-03-26
EP0396069B1 (de) 1994-06-22
DK0396069T3 (da) 1994-07-25
HUT53901A (en) 1990-12-28
CA2016089C (en) 1998-12-01
ATE107643T1 (de) 1994-07-15
IE901639L (en) 1990-11-05
IE63662B1 (en) 1995-05-31
US6017909A (en) 2000-01-25
EP0396069A1 (de) 1990-11-07
ES2055216T3 (es) 1994-08-16
US5998403A (en) 1999-12-07
JPH02295987A (ja) 1990-12-06
YU86390A (en) 1992-05-28
HU206110B (en) 1992-08-28
DE59006184D1 (de) 1994-07-28
HU902678D0 (en) 1990-09-28
FI902244A0 (fi) 1990-05-04
NO901985L (no) 1990-11-06
US5859003A (en) 1999-01-12

Similar Documents

Publication Publication Date Title
PT93946A (pt) Processo para a preparacao de sais de azelastina com solubilidade melhorada e de composicoes farmaceuticas que os contem
BR0010555A (pt) Inibidores de neuraminidases
BR9407047A (pt) Processo para separaçao de uma proteina de uma soluçao aquosa de proteinas
ES2168334T3 (es) Composicion para el tratamiento de la piel.
BR9611533A (pt) Lipopoliamina composição e utilização e processo de preparação de uma lipopoliamina
RU2000106434A (ru) N-алканоилфенилаланиновые производные
PT84823B (pt) Processo para a preparacao de novos derivados de imidazois 1-substituidos com accao inibidora da dopamina-beta-hidroxilase e de composicoes farmaceuticas que os contem
PT99727A (pt) Processo para a preparacao de composicoes farmaceuticas estaveis de calcitonina humana
BR9408392A (pt) Derivados de ácidos arilacéticos e sua utilização como fungicidas
PT90743A (pt) Processo para a preparacao de derivados de hirudina com accao retardada e de composicoes farmaceuticas que os contem
DK0763098T3 (da) Fremgangsmåde til fraktionering af vinasse
ATE172757T1 (de) Eisenphosphatierung unter verwendung von substituierten monocarbonsäuren
BR9713159A (pt) Composição substancialmente sólida, composto, composição de sal substancialmente sólida, mistura, e, processo para preparar um composto
ES2037763T3 (es) Metodo para preparar compuestos no naturales afines a la ceramida.
PT100756A (pt) Novos derivados de gangliosidos, processo para a sua preparacao e composicoes farmaceuticas que os contem
DK160316C (da) Analogifremgangsmaade til fremstilling af beta-casomorphinanaloge peptider samt pharmakologisk acceptable syreadditionssalte og metalkomplekser deraf
SE8303136D0 (sv) Derives de lŸoxazolidinone-2 n-arylee optiquement actifs, inhibiteurs specifiques et reversibles de la monoamine oxydase de type b et leur procede de preparation
ES520493A0 (es) Procedimiento para la preparacion de insulinas a partir de compuestos analogos a preproinsulina.
DE69000719T2 (de) Hautreinigungsmittel.
SE8502315D0 (sv) Improved transamination process for producing amino acids
AR008236A1 (es) Forma cristalina anhidra del clorhidrato de acido r(-)-n-(4,4-di(3- metiltien-2-il)but-3-enil)-nipecotico, una composicion farmaceutica y el uso de dicha sal cristalina para la preparacion de una composicion farmaceutica
PT94685A (pt) Processo para a preparacao de 2-imidazolinas substituidas e de composicoes farmaceuticas que as contem
PT98700A (pt) Processo para a preparacao de acidos aminometanofosfonico e de acidos aminometil-fosfinicos
ES511478A0 (es) Procedimiento para la obtencion de curtientes hidrosolubles o autodispersantes.
BR0207473A (pt) Processo para preparar ácido d-pantotênico e/ou seus sais, e, composição para uso como aditivo de alimento para animal e/ou suplemento de alimento para animal

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960816

PC3A Transfer or assignment

Free format text: ASTA MEDICA HEALTH PRODUCTS GMBH & CO. KG DE

Effective date: 20020909

PD3A Change of proprietorship

Free format text: VIATRIS GMBH & CO. KG DE

Effective date: 20020909

Free format text: ASTA MEDICA GMBH DE

Effective date: 20020909

TE3A Change of address (patent)

Free format text: ASTA MEDICA AKTIENGESELLSCHAFT DE

Effective date: 20020909

TE3A Change of address (patent)

Free format text: VIATRIS GMBH & CO. KG DE

Effective date: 20050506

PD4A Change of proprietorship

Owner name: MEDA PHARMA GMBH & CO. KG, DE

Effective date: 20070604

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20110816